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Loss  of  ATM  kinase,  a transducer  of the DNA  damage  response  and redox  sensor,  causes  the neurodegen-
erative  disorder  ataxia-telangiectasia  (A-T).  While  a  great  deal  of  progress  has  been made  in  elucidating
the  ATM-dependent  DNA  damage  response  (DDR)  network,  a key  challenge  remains  in  understandingTM
eurodegeneration
eural stem cells
PS  cells
NA damage response
ypoxia
the  selective  susceptibility  of the  nervous  system  to faulty  DDR.  Several  factors  appear  implicated  in the
neurodegenerative  phenotype  in A-T,  but which  of  them  plays  a crucial  role  remains  unclear,  especially
since  mouse  models  of  A-T do not  fully  mirror  the  respective  human  syndrome.  Therefore,  a  number  of
human  neural  stem  cell  (hNSC)  systems  have  been  developed  to get an  insight  into  the  molecular  mech-
anisms  of  neurodegeneration  as  consequence  of  ATM  inactivation.  Here  we  review  the  hNSC  systems
developed  by us  an  others  to model  A-T.
n acce© 2013 Elsevier B.V. 
. Introduction
Ataxia-telangiectasia (A-T) is an inherited neurodegenerative
isorder arising from inactivating mutations in ATM, a gene encod-
ng a protein kinase regarded as a key regulator of the DNA damage
esponse (DDR) to double-strand breaks (DSBs) [1–3]. Concordant
ith this function, cells from A-T patients are hypersensitive to ion-
zing radiation and defective in cell cycle checkpoint arrest [3,4].
he most prominent neuropathological ﬁnding in A-T is cerebel-
ar ataxia, which involves a signiﬁcant loss of Purkinje and granule
ells; to some extent, loss of neurons in striatum and substantia
igra is also found [5]. Although the neurodegenerative phenotype
as been attributed to a defective response to DNA breaks in pre-
nd post-mitotic neurons [6], oxidative stress and reduced anti-
xidant defence may  seemingly play a role [7]. For instance, A-T
atients show persistent oxidative stress at cellular level, whereas
rains and DNA from ATM knock-out mice exhibit increased sig-
atures of reactive oxygen species (ROS) [8,9], and furthermore
ietary supplementation of NAC (N-acetyl-cysteine) ameliorates
xidative DNA damage [10] and protects Purkinje cells from redox-
nduced death [11]. At molecular level, the persistent oxidative
tress in A-T cells was recently attributed to the capacity of ATM
Opeo undergo disulﬁde bond formation and activation in response to
xidants [12], a mechanism clearly distinct from that elicited by
NA breaks. Hence, ATM works in redox sensing and signalling, and
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Open access under CC BY-NC-ND license.the loss of redox balance in A-T may  be central to the neuropatho-
logical phenotype. Moreover, unscheduled re-entry of terminally
differentiated post-mitotic neurons into the cell cycle following
exposure to stimuli such as chronic inﬂammation, hypoxia and
oxidative stress initiates an apoptotic response [13,14], and this
cell cycle reactivation may  be particularly noxious to Purkinje and
granule cells in A-T. While mostly nuclear, in neurons a fraction
of ATM is localized in the cytoplasm [15,16], where it function-
ally interacts with the synaptic proteins VAMP2 and Synapsin-1.
Together with the defective long term potentiation and synaptic
vesicle recycling in ATM-deﬁcient brains, these ﬁndings lead to
hypothesize that the neurological symptoms of A-T may  also arise
from an impaired cytoplasmic activity of ATM separate from its
DNA damage response [17]. Most recently, neurodegeneration in A-
T  has been linked to the loss of the cytoplasmic histone deacetylase
HDAC4 and its nuclear accumulation, with consequent suppres-
sion of neuronal gene expression [18]. Interestingly, the evidence
that the malfunction of ATM severely impairs glial cell functionality
and vascular integrity, has led to the hypothesis that the cerebellar
degeneration in A-T is a reﬂection of a dysfunctional neuro-glio-
vascular unit [19]. In summary, several factors appear implicated
in the neurodegenerative phenotype of A-T, but which of them are
most crucial is still debated, primarily because of the unavailabil-
ity of human model systems able to recapitulate the neurological
disease in vitro.
ss under CC BY-NC-ND license.A  potent experimental tool to study neurodegeneration is
offered by genetically stable neural stem cells (NSCs) derived
from multiple locations within the mammalian brain, endowed
with in vitro self renewal capacity and able to differentiatiate into
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eurons, astrocytes and oligodendrocytes, in proportions that
irror their physiological distribution [20–22]. Human NSCs
hNSCs), for instance, can generate neurons with a GABAergic, glu-
amatergic or dopaminergic phenotype and electrophysiological
ction potentials [22,23], and upon transplantation can improve
ensorimotor functions and generate synaptic junctions [21,24,25].
blation of ATM expression in these cells can be achieved by shRNA
ilencing, as we have recently shown [26]. The downregulation of
TM expression in human embryonic stem cells (hESCs), which
an be directed to differentiate down speciﬁc neural cell lineages,
lso offers an in vitro model to study neurodegeneration [27,28].
 prominent advance in stem cell biology is represented by the
ossibility of generating human induced pluripotent stem (iPS)
ells by reprogramming ﬁbroblasts and other somatic cells. Owing
o their capacity to differentiate into pure populations of speciﬁc
ell types, iPS cells provide a unique opportunity for disease mod-
lling, which is of paramount importance for neuropathological
isorders. In the case of A-T, the direct reprogramming of patients’
broblasts into iPS cells and conversion to functional neurons has
een recently reported [29,30].
Here, we review the human cell systems that have been devel-
ped in order to perform in vitro analysis regarding the outcome of
TM inactivation in relation to DNA damage response and repair,
usceptibility to oxidative stress and neural differentiation, with
he overall goal to get an insight into the molecular mechanisms of
eurodegeneration in A-T.
. Available hNSCs as in vitro models of A-T
NSCs are self-renewing, multipotent precursor cells that reside
n specialized regions of the embryonic and adult central nervous
ystem (CNS) and participate in its homeostasis.
Primary cultures of human NSCs have been isolated from
natomically distinct fetal brain regions (e.g. midbrain and cor-
ex) and grown in vitro as neurospheres (N) in the presence of EGF
nd FGF-2 [25,31]. These cells can be maintained long-term in a
roliferative undifferentiated state and can be induced to differen-
iate into the three major CNS cell types, i.e. neurons, astrocytes,
nd oligodendrocytes, in proportions that mirror their physiologi-
al distribution (Fig. 1A). To overcome some limitations (e.g. slow
rowth), primary NSCs have been immortalized with a retroviral
ector encoding the v-myc oncogene (ihNSCs), and have shown to
etain self-renewal and multipotential capacity [23,31]. The impact
f ATM on the biological properties of these cells has been gener-
lly studied in two ways, either by chemical inhibition of ATM with
U-55933 [32] or by lentiviral shRNA-mediated stable knockdown
f ATM (shATM) [26], although it has been argued that inhibition
f ATM activity and knockdown of the protein do not fully mirror
he broad spectrum of A-T-causing mutations [33,34], in line with
ecent ﬁndings showing that mice expressing a kinase-inactive
TM die during embryonic development, whereas ATM-null mice
re viable [34].
Pluripotent human embryonic stem cells (hESCs), which can
e differentiated into neural progenitors and mature neurons and
strocytes, provide another powerful model system to assess the
ffects of loss or inactivation of ATM. Also for these studies, ATM
as either been stably knockdown by transducing hESCs with
entiviruses harbouring shRNA against ATM [27,35], or chemically
nhibited with KU-55933 [28].
Interestingly, neuronal models of A-T based on the use of
atients’ tissues are currently being developed. For example,
lfactory mucosa-derived neurospheres (ONS) have recently been
stablished from several A-T patients and have been shown to dif-
erentiate in vitro into neurons, astrocytes and oligodendrocytes
30].r 12 (2013) 605– 611
Finally, patient-derived induced pluripotent stem (iPS) cells
provide a powerful tool for disease modelling. To address the role
of ATM in neurodegeneration, we and others [29,30] have gen-
erated iPS cells by reprogramming ﬁbroblasts from A-T patients
and normal donors by the introduction of pluripotency factors
(Oct4/Klf4/Sox2/cMyc). Moreover, we  have also established condi-
tions to generate from iPS cells stable proliferating neural precursor
cell (NPC) lines expressing Nestin and Sox2, which can be induced
to differentiate into -Tubulin III and MAP2 positive neurons
(Fig. 1B) expressing GABAergic and glutamatergic markers, and
which acquire electrophysiological function upon maturation [29].
Although the differentiation in a complete range of neuronal sub-
types has not yet been achieved, this model system is extremely
promising as it allows to study patient-derived cells which retain
the original disease-causing mutation and can be differentiated in
virtually all cell types.
3.  The DNA damage response and repair in pre- and
post-mitotic neural cells
Upon terminal differentiation, rapidly proliferating neuropro-
genitors exit the cell cycle and become postmitotic. As the repair of
DNA DSBs occurs through either homologous recombination (HR)
or non-homologous end joining (NHEJ), the former operating in
dividing cells while the latter also in non-dividing cells [36], the cel-
lular answer to genotoxic damage may  differ according to the cell
cycle phase. Moreover, it has been shown that in human neuron-
like cells the levels of ATM and other DDR components, e.g. ATR
and NBS1, are downregulated during neuronal differentiation, with
consequent attenuation of the damage response in non-dividing
versus dividing cells [37] (Fig. 2A). Clearly, the availability of hNSCs
offers the opportunity to study these phenomena in relation to ATM
deﬁciency.
We have previously demonstrated that the DDR of dividing ihN-
SCs is defective upon ablation of ATM by shRNA interference, as
evident from the reduced phosphorylation of ATM substrates [26].
Moreover, the disappearance of -H2AX, an indicator of ongoing
DSB repair, is markedly delayed in shATM cells, indicating that
ATM deﬁciency, like in other dividing cell types, delays the DNA
repair also in hNSCs. By contrast, in terminally differentiated shATM
ihNSCs, the number of -H2AX foci 30 min  following DNA dam-
age is greater than in control cells, while the resolution of the foci
is only modestly delayed (Fig. 2B), suggesting a minor depend-
ence on ATM for DSB repair. It should be noted that, compared to
ATM-proﬁcient neurons, non-dividing neurons from ATM-deﬁcient
neural progenitors obtained from hESCs are virtually negative for
-H2AX expression [27].
4.  Oxidative stress
Oxygen  regulates the homeostasis, apoptosis and differen-
tiation of stem cells and committed progenitors in the central
nervous system, where its levels range from about 0.55–8% [38,39].
Low oxygen tension (hypoxia), a stress condition encountered in
a variety of neuropathological states such as cerebral ischemia, is
known to promote an undifferentiated state in several stem cells
and progenitor cells [21] and to induce a paradoxical increase in the
production of mitochondrial ROS, which further increase intracel-
lular stress [40,41]. In fact, hypoxia activates adaptive mechanisms
involving the stabilization of the hypoxia-inducible factor 1
(HIF-1) and the transcription of HIF-1-regulated genes [3]. A
link between hypoxia and ATM was  recently established in studies
demonstrating that ATM mediates the phosphorylation of HIF-1
on Ser696, and this modiﬁcation causes the downregulation of the
sensor of nutrient and energy sufﬁciency mTORC1, which acts as
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Fig. 1. ihNSC and iPS derived neurons. (A) The cartoon illustrates the maintenance and differentiation of ihNSCs. Cells are grown as neurospheres (N) in medium containing
EGF and FGF-2, and mechanically disaggregated for expansion. After 24 h (D0; D: days of differentiation), cells appear as doublets which are plated on laminin-coated surfaces
and  grown without EGF for 3 days, in order to induce progenitor differentiation. FGF-2 is then removed to promote the generation of mature neurons, oligodendrocytes and
astrocytes. The different cell types are detected by IF using lineage-speciﬁc phenotypic markers. (B) A-T patient-derived skin ﬁbroblasts are reprogrammed into iPS cells. iPS
cells  express the pluripotency markers Tra-1-81 and upon neutralization give rise to a self-renewing population of NPCs expressing Nestin. NPCs can be further differentiated
into mature neurons expressing MAP2. A-T iPS cells are ATM-deﬁcient and express the pluripotency factor Oct3/4 (western blot, left). Upon neuralization, NPCs downregulate
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eriﬁed with anti-vinculin antibodies.
 restriction point under stress conditions [42]. Loss of hypoxia-
ependent inhibition of mTORC1 sensitizes ATM-deﬁcient cells to
53-dependent apoptosis [42]. Hypoxia-induced ROS are currently
elieved to be the key cytosolic signal that elicits the accumulation
f HIF-1 by inhibiting prolyl-hydroxylase (PHD) activity through
n unknown mechanism [43]. Deregulated ROS can be neuropatho-
ogical and given that ROS can activate ATM [39] to downregulate
TORC1 [44], it is possible that ATM mediates certain cellular
tress responses through the hypoxia-induced ROS. However,whereas -Tubulin III increases (western blot, right). Protein loading per lane was
little  is known about the role of hypoxia in neural cells in relation
to ATM. We  have recently investigated this aspect and one of the
most striking ﬁndings in ATM-proﬁcient ihNSCs was  the dramatic
upregulation by hypoxia (1% O2) of the levels of ATM and of its
family members ATR, DNA-PKcs and mTOR (Fig. 3A, left), but not
of the ATM substrates Smc1, NBS1, Mre11, Chk2 and Chk1 (not
shown). This phenomenon appears to depend partly on enhanced
transcription and partly on AMPK activity. We also found that
ATM deﬁciency reduces the accumulation of HIF-1 and Carbonic
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Fig. 2. Response of ihNSC to IR-induced DNA damage. (A) At the indicated days of differentiation (D) cells were irradiated and analyzed 1 h later by western blot for the
autophosphorylation of ATM-S1981 and phosphorylation of the ATM targets Smc1-S966, Chk2-T68 and p53-S15. Protein loading per lane was veriﬁed with anti--Actin
antibodies (B) The formation and loss of damage-induced -H2AX nuclear foci was assessed on cells at D0 or D17 (cultured and differentiated in 5% or 1% O2, as indicated)
which were treated with 1 Gy or 0.88 nM NCS respectively, collected at the indicated time points and IF-labeled for -H2AX. For each treatment, the number of foci was
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Icored from over 100 cell nuclei per duplicate preparations and from three indepen
hATM  was  statistically signiﬁcant (**P < 0.01) except for those indicated with n.s.
nhydrase IX (CAIX) in proliferating ihNSCs grown under hypoxia
Fig. 3A, right). This reduced accumulation of HIF-1 and especially
AIX is also observed in non-dividing terminally differentiated
ells (Fig. 3B), indicating that the expression of these molecules is
artially dependent on ATM.
. Differentiation/maturationATM deﬁciency appears to impact on hNSC differentiation.
ndeed, while the yield of neurons expressing MAP2 and -Tubulin
II markers is unaffected by ATM deﬁciency, that of GABAergicexperiments (mean ± S.D.). For each time point, the difference between shCon and
neurons falls by 50% (Fig. 4A). Notably, GABA signaling plays an
important role in adult neurogenesis, through a mechanism in
which GABA induces the phosphorylation of H2AX by ATM/ATR,
and this epigenetic change within the subventricular zone niche
restricts the proliferation of neural stem cells and neuronal output
[45,46]. Whether the reduced yield of GABAergic neurons in
ATM-deﬁcient ihNSCs arises from a dysfunctional GABA signal-
ing owing to ATM deﬁciency and somehow limiting a speciﬁc
neuronal output, remains unknown. Nevertheless, this in vitro
result agrees with pathological and clinical ﬁndings showing a
GABA deﬁciency in the cerebellum of an A-T patient [47], and
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Fig. 3. ATM depletion and hypoxia markers accumulation. (A, left) Upregulation by hypoxia (1% O2) of ATM and other family members in proliferating ihNSCs as detected by
western  blot. (A, right) HIF-1 and CAIX protein levels in proliferating ihNSCs in relation to hypoxia and ATM deﬁciency. The graphs refers to the densitometry quantiﬁcation
of the western blot bands (**P < 0.01; *P < 0.05). (B) Hypoxic markers accumulation during differentiation. Cells grown in 1% O2 were collected at various days of differentiation
and the expression of HIF-1 and CAIX was  examined by western blot. Protein loading per lane was  veriﬁed with anti-vinculin or anti--Actin antibodies.
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bmelioration of the ataxia manifestation by treatment with a
ABA-analog [48].
Interestingly,  oxygen levels also affect the differentiation
f neural progenitor cells [49]. Concordant with this, we have
bserved that the amount of neurons expressing -Tubulin III
s markedly reduced in ihNSCs differentiating under hypoxia,
lthough to the same extent in ATM-deﬁcient and–proﬁcient
ells. Hypoxia also affects the yield of GABAergic neurons, but
o a greater extent in ATM-deﬁcient than in control ihNSCs, and
he potassium channel-interacting protein-1 (KCHIP-1), predom-
nantly expressed by GABAergic neurons [43], also appears to
e markedly dependent on oxygen tension, since the fraction ofpositive cells falls substantially under hypoxia, and to a higher
degree in ATM-deﬁcient ihNSCs (Fig. 4A).
ATM-deﬁciency also attenuates the yield of GalC- and CNPase-
expressing oligodendrocytes [26] and furthermore, when ihNSCs
are induced to differentiate under oxidative stress conditions
achieved by the glutathione-depleting agent BSO (Buthion-
ine Sulfoximine) or by hypoxia, a remarkable vulnerability of
oligodendrocytes to ATM deﬁciency is observed (Fig. 4A and
B).
Quite signiﬁcantly, these results indicate that ATM deﬁciency
does not appear to impair overall neurogenesis, though it partially
affects oligodendrogenesis.
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Fig. 4. ATM depletion, hypoxia and effects on differentiation. ihNSCs at D17 of differentiation in the indicated O2 concentrations were IF-labelled with antibodies speciﬁc for
neurons  (-Tubulin III), GABAergic neurons (GABA) and oligodendrocytes (GalC). Nuclei were counterstained with DAPI and cells scored by ﬂuorescence microscopy. Results
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[n  each graph were obtained from the analysis of three independent experiments, a
.s.:  not signiﬁcant). The representative IF photos refer to shCon at D17 of differen
ontaining 1 mM NAC or 1 mM BSO, a glutathione-depleting and oxidative stress-i
**P  < 0.01; *P < 0.05).
. Concluding remarks
As  animal models of A-T do not faithfully reproduce the
uman syndrome, attempts have been made to generate and use
uman neural stem cell lines derived from embryos, fetal brain
r adult brain tissues, to study the mechanisms that underlie the
eurodegenerative disease. hNSCs are a renewable source of undif-
erentiated cells, can be induced to differentiate into functional
eurons and glia, and are amenable to experimental genetic manip-
lation. Studies with such cells are certainly providing important
lues on the role of ATM in DDR and neuronal differentiation
rogression and maturation, as well as on the vulnerability to geno-
oxic and oxidative agents. However, since the characteristics of
NSCs either derived from ES cells or isolated from different regions
f the brain can differ, possibly reﬂecting normal developmen-
al patterns, it must be recognized that despite many advantages,
he use of these stem cells for disease modelling has limitations
50]. Human iPS cells generated from reprogrammed A-T ﬁbro-
lasts and capable of generating a variety of functional neurons
ffer an additional tool to study neurodegeneration also as func-
ion of the disease-associated genetic mutation. A current challenge
s to direct the neural differentiation of iPS cells towards spe-
iﬁc neuronal subtypes, e.g. Purkinje cerebellar neurons, which
re speciﬁcally sensitive to ATM deﬁciency. This would allow the
nvestigation of the effects of A-T-causing mutations using the cell
opulation which is directly involved in the neurodegenerative
henotype of A-T.
[niﬁcant differences between shCon and shATM are indicated (**P < 0.01; *P < 0.05;
 in 5% O2. (B) ihNSCs were induced to differentiate on glass coverslips in medium
ng agent, and then IF-labeled with antibodies speciﬁc for oligodendrocytes (GalC)
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